BusinessAugust 18, 2026
biosimilars
BY-oh-SIM-ih-lerz
Definition
Highly similar versions of approved biologic medical products that have no clinically meaningful differences from the original product in terms of safety, purity, or potency.
Etymology
The term is a portmanteau of 'bio-' (from Greek 'bios', meaning life) and 'similar', indicating products that are structurally and functionally comparable to a reference biologic.
In the news
The article highlights the transition of the Indian pharmaceutical industry toward producing biosimilars as part of a strategic shift from basic generic medicines to high-value, cutting-edge therapies.
Telangana aims to emerge as India’s life sciences innovation capital with $25B investment target by 2030
Read the full article ↗BioSpectrum India